Monte Rosa Therapeutics, Inc. insider trading activity
Understanding Insider Activity at Monte Rosa Therapeutics, Inc.
Welcome to our dedicated page for Monte Rosa Therapeutics, Inc. (Nasdaq: GLUE) insider trading activity, sourced directly from the SEC Form 4 Filings. Here, you'll find the latest buying and selling activities undertaken by Monte Rosa Therapeutics, Inc.'s key insiders, providing a unique window into the company's internal sentiments.
How to Use This Data:
Below, you can view insider transactions that were reported to the SEC within the last 365 days.
While insider trading can hint at a company's prospects, it's crucial to approach this data as part of a broader investment strategy. Look for patterns over time, significant buys or sells, and consider other market factors before making investment decisions.
Scroll down to view the most recent insider transactions for Monte Rosa Therapeutics, Inc., and gain a better understanding of the confidence and considerations of those intimately tied to the company's success.
Track insider trades for GLUE| Ticker | Time & Date | Filing | Link |
|---|---|---|---|
| GLUE | 8:35:43 PM 10/30/2024 | Versant Venture Capital VI, L.P. sold 157895 shares of Monte Rosa Therapeutics, Inc. (GLUE) for ~$1491028 | Filing |
| GLUE | 8:40:59 PM 9/24/2024 | Versant Venture Capital VI, L.P. sold 1132566 shares of Monte Rosa Therapeutics, Inc. (GLUE) for ~$7395655 | Filing |
| GLUE | 10:44:19 PM 9/13/2024 | Versant Venture Capital VI, L.P. sold 567213 shares of Monte Rosa Therapeutics, Inc. (GLUE) for ~$3404761 | Filing |
| GLUE | 8:15:03 PM 7/9/2024 | Dunn Edmund(Principal Accounting Officer) sold 1610 shares of Monte Rosa Therapeutics, Inc. (GLUE) for ~$6166 | Filing |
| GLUE | 8:10:07 PM 6/5/2024 | Dunn Edmund(Principal Accounting Officer) sold 1207 shares of Monte Rosa Therapeutics, Inc. (GLUE) for ~$4876 | Filing |